Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Lymphoma 1Hodgkin Disease 1

Interventions

Cyclophosphamide 18fludarabine phosphate 12pembrolizumab 11Nivolumab 11Brentuximab Vedotin 11Mycophenolic Acid 10Doxorubicin 10fludarabine 9Dacarbazine 9Whole-Body Irradiation 8Etoposide 8Vinblastine 7Specimen Handling 7Magnetic Resonance Spectroscopy 7Filgrastim 7Cyclosporine 7Granulocyte Colony-Stimulating Factor 6Sirolimus 5Radiotherapy 5Peripheral Blood Stem Cell Transplantation 5Melphalan 5Gemcitabine 5Busulfan 5Tacrolimus 4pegfilgrastim 3Vinorelbine 3Stem Cell Transplantation 3Rituximab 3Radiation 3Prednisone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hodgkin Disease × Pharmacokinetics × 90 days × Clear all
NCT05540340 2026-03-06

A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant

Memorial Sloan Kettering Cancer Center

Phase 1 Active not recruiting
39 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡